ストックスクリーナーアプリを入手
46.85
5.23%
2.33
プレマーケット:
46.73
-0.12
-0.26%
前日終値:
$44.52
開ける：
$44.52
24時間の取引高:
581.23K
Relative Volume:
0.81
時価総額：
$1.74B
収益：
$154.15M
当期純損益:
$-33.58M
株価収益率:
-48.80
EPS:
-0.96
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
+13.44%
1か月 パフォーマンス:
+32.68%
6か月 パフォーマンス:
+58.76%
1年 パフォーマンス:
+23.03%
1日の値動き範囲:
$43.54
$46.87
1週間の範囲:
$39.64
$46.87
52週間の値動き範囲:
$20.85
$50.72
Harrow Inc Stock (HROW) Company Profile
HROW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
46.85 | 1.65B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
120.41 | 54.02B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.28 | 45.21B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.53 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.41 | 31.93B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
485.21 | 20.71B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 開始されました | BTIG Research | Buy |
| 2025-06-10 | 開始されました | William Blair | Outperform |
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
Harrow (NASDAQ:HROW) Shares Up 10.2%Time to Buy? - MarketBeat
Harrow (HROW) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Harrow, Inc. (NASDAQ:HROW) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Yahoo Finance
Should Vevye’s CVS Formulary Win Prompt a Closer Look from Harrow (HROW) Investors? - simplywall.st
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS (NASDAQ:HROW) - Seeking Alpha
Creative Planning Grows Holdings in Harrow, Inc. $HROW - MarketBeat
Intech Investment Management LLC Sells 6,798 Shares of Harrow, Inc. $HROW - MarketBeat
Insider Sell: Why Harrow Inc. stock appeals to dividend seekersMarket Trend Review & Weekly High Return Stock Opportunities - moha.gov.vn
Market Trends: Is Harrow Inc. stock attractive for income investors - moha.gov.vn
How Harrow Health Inc. 8.625% Senior Notes Due 2026 (HROWL) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Harrow to Present at Two Investor Conferences in December - Sahm
Is Harrow Inc. stock attractive for income investorsBull Run & Daily Chart Pattern Signal Reports - moha.gov.vn
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - Yahoo Finance
Penn Capital Unwinds $17.1 Million BGC Stake as Broker Posts 31% Revenue Surge - The Motley Fool
Following a 2.8% Decline Over Last Year, Recent Gains May Please Harrow, Inc. (NASDAQ:HROW) Institutional Owners - 富途牛牛
A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance - Yahoo Finance
Harrow (NASDAQ: HROW) to join BTIG Ophthalmology Day and Piper Sandler conference - Stock Titan
Why Harrow Inc. stock remains on watchlistsJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Health Care Notes: Analysts raise HCA price targets - Nashville Post
Should I hold or sell Harrow Inc. stock in 2025Portfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Harrow, Inc. Hits Day High with 7.65% Surge in Strong Intraday Performance - Markets Mojo
How Harrow Inc. stock performs in rising dollar environment2025 AllTime Highs & Risk Controlled Stock Alerts - newser.com
How Harrow Inc. stock reacts to job market dataJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
What insider trading reveals about Harrow Inc. stockBear Alert & Momentum Based Trading Signals - newser.com
Can Harrow Inc. stock sustain market leadership2025 Price Momentum & AI Enhanced Trading Alerts - newser.com
Harrow, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HROW) 2025-11-19 - Seeking Alpha
How Harrow Inc. stock performs in rate cut cyclesEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Harrow officially acquires Melt Pharmaceuticals - Eyes On Eyecare
Detecting price anomalies in Harrow Inc. with AIJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Will Harrow's (HROW) Return to Profitability Reshape Its Growth Narrative? - simplywall.st
Analyzing Harrow Inc. with risk reward ratio charts2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Best data tools to analyze Harrow Inc. stockJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Harrow Completes Its Acquisition of Melt Pharmaceuticals - VisionMonday.com
What analysts say about Harrow Inc stockStock Price Targets & Affordable Growth Investments - earlytimes.in
Will Harrow Inc. stock pay special dividendsMarket Trend Report & Weekly Top Stock Performers List - newser.com
Harrow completes acquisition of Melt Pharmaceuticals By Investing.com - Investing.com Nigeria
Harrow (HROW) Finalizes Acquisition of Melt Pharmaceuticals - GuruFocus
Harrow Health Completes Acquisition of Melt Pharmaceuticals - TipRanks
[8-K] HARROW, INC. Reports Material Event | HROW SEC FilingForm 8-K - Stock Titan
Harrow Closes Melt Pharmaceuticals Acquisition - MarketScreener
Harrow completes acquisition of Melt Pharmaceuticals - Investing.com
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
7.96%
0.86%
大文字化:
|
ボリューム (24 時間):